- Barriers to Insulin Initiation
Reasons for failing to initiate prescribed insulin (primary nonadherence) are
poorly understood. We investigated barriers to insulin initiation following a new prescription.
- Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus
Although the largest improvement in glycemic control occurs within the first 90 days of insulin therapy, little is known about early persistence on insulin therapy. This research aimed to identify predictors of early discontinuation and of subsequent restart of basal or mixture insulin among patients with type 2 diabetes mellitus (T2DM) and to assess the economic cost associated with such behaviors over a 1-year period.
- Clinical outcomes after insulin initiation in patients with type 2 diabetes: 6-month data from the INSTIGATE observational study in five European countries
To examine insulin regimens and factors that affect glycaemic control at 6 months after initiation of insulin
therapy in patients with type 2 diabetes mellitus.
- Twenty-First Century Behavioral Medicine: A Context for Empowering Clinicians and PatientsWith Diabetes
In the past decades, the sophistication of treatments for diabetes has increased dramatically, and evidence for effective interventions has proliferated. As a result, it is now possible to achieve excellent glucose control and reduce the risk of many of the complications associated with the disease. Despite these advances, however,many people with diabetes have less than optimal metabolic control and continue to suffer from preventable complications.
The full access to the selected publications is provided through and unrestricted grant from Lilly :